MSH2 and endometrial cancer: Excluding those 6 patients, 13 endometrial cancer patients (56.5%) were identified in total; the causative gene was MLH1 in 6 patients (42.8%), MSH2 in 3 patients (75%), and MSH6 in 4 patients (80%).